We are investigating the sale of Nightstar Therapeutics plc (NasdaqGS: NITE) to Biogen Switzerland Holdings GmhH. Under the terms of the proposed transaction, Nightstar stockholders will receive $25.50 in cash for each Nightstar share they own.
We are investigating the sale of Nightstar Therapeutics plc (NasdaqGS: NITE) to Biogen Switzerland Holdings GmhH. Under the terms of the proposed transaction, Nightstar stockholders will receive $25.50 in cash for each Nightstar share they own.